DOI QR코드

DOI QR Code

A Case Study of Central Serous Chorioretinopathy Using Ortho-Cellular Nutrition Therapy (OCNT)

세포교정영양요법(OCNT)을 이용한 중심 장액성 망막염 사례 연구

  • Received : 2023.05.31
  • Accepted : 2023.05.31
  • Published : 2023.05.31

Abstract

Objective: Report of a case study on the resolution of central serous chorioretinopathy through cellular nutrition therapy (OCNT). Methods: A Korean male born in 1965 who has been diagnosed with central serous chorioretinopathy in the left eye since August 22, 2022. Results: Complete resolution of central serous chorioretinopathy following the implementation of nutritional therapy. Conclusion: Nutritional therapy may be beneficial in alleviating symptoms in patients with central serous chorioretinopathy

Keywords

References

  1. Liegl, R., & Ulbig, M. W. Central serous chorioretinopathy. Ophthalmologica, (2014) 232(2), 65-76. https://doi.org/10.1159/000360014
  2. Shin, Y. U. Review and update for central serous chorioretinopathy. Hanyang Medical Reviews, (2017) 37(1), 10-17.. https://doi.org/10.7599/hmr.2017.37.1.10
  3. Yannuzzi, L. A. Type-A behavior and central serous chorioretinopathy. Retina (Philadelphia, Pa.), (1987) 7(2), 111-131. https://doi.org/10.1097/00006982-198700720-00009
  4. Boscia, F. When to treat and not to treat patients with central serous retinopathy. Retin Today, (2010) 42, 32-34.
  5. Singh, R. P., Sears, J. E., Bedi, R., Schachat, A. P., Ehlers, J. P., & Kaiser, P. K. Oral eplerenone for the management of chronic central serous chorioretinopathy. International Journal of Ophthalmology, (2015) 8(2), 310.
  6. Lotery, A., Sivaprasad, S., O'Connell, A., Harris, R. A., Culliford, L., Ellis, L., ... & Grice-Holt, A. Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial. The Lancet, (2020) 395(10220), 294-303. https://doi.org/10.1016/S0140-6736(19)32981-2
  7. Pecora, J. L. Ibuprofen in the treatment of central serous chorioretinopathy. Annals of Ophthalmology, (1978) 10(11), 1481-1483.
  8. Wang, P., Chin, E. K., & Almeida, D. Antioxidants for the treatment of retinal disease: summary of recent evidence. Clinical Ophthalmology, (2021) 1621-1628.
  9. Schnebelen, C., Viau, S., Gregoire, S., Joffre, C., Creuzot-Garcher, C. P., Bron, A. M., ... & Acar, N. Nutrition for the eye: different susceptibility of the retina and the lacrimal gland to dietary omega-6 and omega-3 polyunsaturated fatty acid incorporation. Ophthalmic Research, (2009) 41(4), 216-224. https://doi.org/10.1159/000217726
  10. Jung, F., Mrowietz, C., Kiesewetter, H., & Wenzel, E. Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers. Arzneimittel-Forschung, (1990) 40(5), 589-593.
  11. Kim, J., Ha, S., Lee, J., Kim, H., Yoon, S., & Kim, Y. (2003). Physiological Activities and Content Analysis of Carotenoids. Korean Journal of Crop Science, 48, 72-78.